Medical diagnoses of Fibromyalgia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Medical diagnoses of Fibromyalgia, diagnostic symptoms according to Wolfe criteria et al., (2010), and Insomnia Disorder identified according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, DSM-V-TR (2014) and actigraphy data (Octagonal Basic Motionlogger®, Ambulatory monitoring; Actwath-64®, Phillips Respironics).
Exclusion criteria
Exclusion criteria: The participants could not show other sleep disturbance identified by a health professional (e.g: Obstructive Sleep Apnea Syndrome, Restless Legs Syndrome), being on medication for sleep, or participating in psychotherapy during the period of data collection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study focused on evaluating the effects of an intervention analytic-behavioral involving two components about pain indicators and sleep in women with FM and insomnia, to know: 1) management of physical environment conditions; and, 2) managing interpersonal relationships. Self-report instruments were used in Initial, Intermediate and final evaluate and follow-up, to assess pain intensity and disability (END / S; FIQ-R; and SF – MPQ), sleep quality (PSQI-Br) and insomnia severity (IGI). Actigraphy was used to measure sleep patterns, considering the 4 participants of study (P1,P2,P3 and P4) For P1 and P3, there is a decrease in the scores of the four instruments, after Phase A and Phase B intervention, with maintenance of these effects in the evaluation of Follow-Up (after 30 days) for P1. For P2, the scores on the instruments (FIQ-R, SF-MPQ, PSQI-Br and IGI) were decreased during the evaluation phases, but the SF-MPQ instrument score increased after phase B, and decreased in the Follow-up evaluation. Finally, P4 presented a considerable reduction of the scores for all the instruments, which was decreasing throughout all evaluation phases, with the result of the overall pain assessment (SF-MPQ), reaching zero in the final evaluation. ;Data showed that the intervention (20 sessions) was effective in improving pain and sleep indicators in all participants. The gains observed in the final assessment were maintained or increased in follow-up measures. However, the results should take into consideration the clinical condition and other variables that may have individually impacted the results. | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical significance was assessed using the JT method (Jacobson and Truax, 1999), which identifies whether the results attributed to intervention, based on scores of the instruments applied in initial and final evaluations, move between the representative ranges clinical and non-clinical.;Clinical significance, JT method, showed that participant 4 went from the clinical population to the non-clinical, in all the indicators evaluated, participant 3 changed the status to non-clinical in relation to sleep quality (PSQI-Br), and participant 1 changed the status to non-clinical in relation to insomnia severity (IGI). Participant 2 remained in the clinical population for all the indicators evaluated, and none of them were moved from the nonclinical to the clinical range after the intervention. | — |
Countries
Brazil
Contacts
Universidade Católica Dom Bosco